Corning and Pfizer announced a long-term, multiyear purchase and supply agreement for Corning Valor Glass vials for a portion of Pfizer's marketed drug products, pending regulatory approval. The release is dated 28 May 2020.
Corning agreed a collaboration with Stevanato Group, a Dese, Italy-based parenteral glass packager, to supply its Corning Valor Glass for injectable drug packaging. The deal extends a relationship dating to 2011 and combines Stevanato's converting technology with Valor Glass.
Corning will develop Corning Valor Glass with Merck and Pfizer, and is expected to expand its facilities and build a new glass plant with an estimated investment of $500 million. The location was not stated.
In July 2017, Corning and Gerresheimer, a Dusseldorf, Germany-based contract packaging company, partnered to supply Valor Glass to the pharmaceutical industry. The two companies have worked together in pharmaceutical glass packaging since 2015.
Corning and Stevanato Group announced a new collaboration to supply Corning Valor Glass, a glass container for injectable drugs, to pharmaceutical customers. The press release is dated 25 July 2017, and no value is given.